SMARCA4 and rhabdoid tumor predisposition syndrome 2: Germline mutations of SMARCA4 have previously been described to be associated with Rhabdoid tumor predisposition syndrome 2, leading to highly aggressive and early-onset tumors such as small cell carcinoma of the ovary, hypercalcemic type36.